Keratolytic winter erythema
|
0.520 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hyperhidrosis disorder
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Erythema
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
pustule
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperhidrosis Palmaris Et Plantaris
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myopathy
|
0.300 |
Biomarker
|
group |
CTD_human |
In this report we examine the activities of the lysosomal endoproteinase cathepsin B and its endogenous inhibitor(s) in the red and white skeletal muscles of guinea pigs with nutritional muscular myopathy induced by vitamin E deficiency.
|
7099197 |
1982 |
Proteinuria
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis.
|
3669494 |
1987 |
Liver neoplasms
|
0.210 |
AlteredExpression
|
group |
BEFREE |
Relative amounts of mRNA for cathepsin B were measured in normal murine liver and three murine tumors, an invasive liver tumor (hepatoma, Hepa cl 9) and two melanoma variants (B16-F1 and B16 amelanotic melanoma, B16a).
|
2924910 |
1989 |
Melanoma, Amelanotic
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Relative amounts of mRNA for cathepsin B were measured in normal murine liver and three murine tumors, an invasive liver tumor (hepatoma, Hepa cl 9) and two melanoma variants (B16-F1 and B16 amelanotic melanoma, B16a).
|
2924910 |
1989 |
Amelanotic Skin Melanoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Relative amounts of mRNA for cathepsin B were measured in normal murine liver and three murine tumors, an invasive liver tumor (hepatoma, Hepa cl 9) and two melanoma variants (B16-F1 and B16 amelanotic melanoma, B16a).
|
2924910 |
1989 |
Rheumatoid Arthritis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis.
|
1953821 |
1991 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
At neutral pH and 24 degrees C, cathepsin B from both normal liver and tumour exhibited a lower Km and a higher kcat./Km than at pH 6.0.
|
1637335 |
1992 |
Familial Alzheimer Disease (FAD)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease.
|
8239266 |
1993 |
Glioma
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Cathepsin B expression and localization in glioma progression and invasion.
|
7954439 |
1994 |
Renal tubular acidosis
|
0.200 |
Biomarker
|
phenotype |
RGD |
Renal tubular cell protein breakdown in uninephrectomized and ammonium chloride-loaded rats.
|
7873730 |
1994 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Four full-length cDNA clones coding for preprocathepsin B were isolated from a human gastric adenocarcinoma cDNA library (AGS 1-6-30-1) and analyzed for possible sequence modifications that might be linked to altered intracellular trafficking and secretion of cathepsin B (CTSB) in malignant tumors.
|
8112600 |
1994 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We have accumulated substantial evidence implicating the cysteine protease cathepsin B in human glioma malignancy.
|
7954439 |
1994 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Gelatinase A (MMP-2) and cathepsin B are proteinases which have been proposed to participate in human tumor invasion and metastasis.
|
7992833 |
1994 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
However, tumor material is considerably richer in cathepsin B activity than normal material.
|
8074469 |
1994 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Increased levels of pro-enzyme and active enzyme forms of gelatinase A (MMP-2) and increased cathepsin B activity were localized in regions of tumor invasion as compared with a matched number of normal epithelial cells from the same patient.
|
7992833 |
1994 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
These data support the hypothesis that cathepsin B plays a role in human glioma progression and invasion.
|
7954439 |
1994 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
We have accumulated substantial evidence implicating the cysteine protease cathepsin B in human glioma malignancy.
|
7954439 |
1994 |
Lung Neoplasms
|
0.040 |
Biomarker
|
group |
BEFREE |
Qualitative differences in the pattern of cathepsin B species between tumor and corresponding normal material or between different histologies of lung tumors were not found.
|
8074469 |
1994 |
Bronchiectasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although the lysosomal cysteine proteinase cathepsin B is alkaline pH-labile, active, stable high molecular mass forms have been reported previously from the culture medium of human and murine mammary tumor explants and the sputum of patients with purulent bronchiectasis.
|
8175724 |
1994 |
Glioblastoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Using RT-PCR (reverse transcription-polymerase chain reaction) and primer extension assays, CTSB mRNA species were found to differ among tissues and between a glioblastoma sample and a cell line derived from it.
|
7622042 |
1995 |